Italy's DiaSorin gets U.S. FDA approval for COVID-19 antibody test

FILE PHOTO: A medical worker takes a blood sample from a man to test for the coronavirus disease (COVID-19) at a converted gym in Cisliano, near Milan, Italy, April 21, 2020. REUTERS/Flavio Lo Scalzo/File Photo

MILAN (Reuters) - Italian diagnostics group DiaSorin said on Saturday it had received an Emergency Use Authorisation (EUA) from the U.S. Food and Drug Administration for a serological test kit for COVID-19.

DiaSorin also said it had recently signed a contract with the Biomedical Advanced Research and Development Authority to obtain funding to make the test available in the United States.